Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Alexion Pharmaceuticals, Inc.    ALXN

Delayed Quote. Delayed  - 08/29 10:00:00 pm
127.99 USD   -1.27%
08/29 ALEXION PHARMAC : European Commission Grants Orphan Drug Designation..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28DJALEXION PHARMAC : Cuts Profit Guidance
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
08/23/2016 08/24/2016 08/25/2016 08/26/2016 08/29/2016 Date
137.42(c) 132.12(c) 129.17(c) 129.63(c) 127.99(c) Last
903 123 1 395 740 1 695 228 1 057 808 955 624 Volume
+0.65% -3.86% -2.23% +0.36% -1.27% Change
More quotes
Financials ($)
Sales 2016 3 078 M
EBIT 2016 1 290 M
Net income 2016 546 M
Debt 2016 1 866 M
Yield 2016 -
Sales 2017 3 671 M
EBIT 2017 1 640 M
Net income 2017 910 M
Debt 2017 1 244 M
Yield 2017 -
P/E ratio 2016 53,05
P/E ratio 2017 32,97
EV / Sales2016 9,93x
EV / Sales2017 8,16x
Capitalization 28 702 M
More Financials
Company
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, engages in the innovation, development, and commercialization of life-transforming therapeutic products for treating patients with severe and ultra-rare disorders.It focuses on developing products for the treatment of diseases in the... 
Sector
Pharmaceuticals
Calendar
10/20Earnings Release
More about the company
Surperformance© ratings of Alexion Pharmaceuticals, I
Trading Rating : Investor Rating :
More Ratings
Latest news on ALEXION PHARMACEUTICALS, I
08/29 ALEXION PHARMACEUTICALS : European Commission Grants Orphan Drug Designation to ..
08/08 ALEXION PHARMACEUTICALS INC : Other Events (form 8-K)
07/29 ALEXION PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL COND..
07/28DJU.S. HOT STOCKS : Hot Stocks to Watch
07/28 ALEXION PHARMACEUTICALS INC : Results of Operations and Financial Condition, Fin..
07/28DJALEXION PHARMACEUTICALS : Cuts Profit Guidance
07/28 ALEXION PHARMACEUTICALS : misses 2Q profit forecasts
07/28 ALEXION PHARMACEUTICALS : Reports Second Quarter 2016 Results
07/18 ALEXION PHARMACEUTICALS : Reports Positive SBC-103 Phase 1/2 Data
07/14 ALEXION PHARMACEUTICALS : Presents New SBC-103 (rhNAGLU enzyme) Phase 1/2 Data o..
More news
Sector news : Biopharmaceuticals
08/29 Mylan to launch generic EpiPen at half the price of original
08/29DJMondelez Walks Away After Hershey Spurns Raised Bid
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test -- Update
08/29DJROCHE : Receives US FDA Emergency Use Authorization for Zika Test
08/29DJSANOFI : Regeneron Announce Positive Trials for Cholesterol Drug
More sector news : Biopharmaceuticals
News from SeekingAlpha
08/29 Alexion Pharma's ALXN1007 an Orphan Drug in Europe for GVHD
08/29 BIOTECH FORUM DAILY DIGEST : Mylan Adjusts Course, Who Is Next Midcap Buyout Tar..
08/23 Reassessing My Thesis On Omeros
08/17 Slimmed-Down Big Pharma Starts Growing Again
08/12 Omeros Corp.'s Path Ahead
Advertisement
Chart ALEXION PHARMACEUTICALS, I
Duration : Period :
Alexion Pharmaceuticals, I Technical Analysis Chart | ALXN | US0153511094 | 4-Traders
Full-screen chart
Technical analysis trends ALEXION PHARMACEU...
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 20
Average target price 172 $
Spread / Average Target 34%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
David L. Hallal Chief Executive Officer & Director
Leonard Bell Chairman
Julie O'Neill Executive Vice President-Global Operations
Vikas Sinha Chief Financial Officer & Executive Vice President
Martin MacKay Executive VP, Global Head-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALEXION PHARMACEUTICAL..-32.90%28 702
CSL LIMITED3.55%37 517
GRIFOLS SA-10.49%13 260
BEIJING TIANTAN BIOLOG..12.63%3 164
JIANGXI BOYA BIO-PHARM..--.--%2 735
3SBIO INC-29.07%2 498
More Results